[Prostate brachytherapy: New techniques, new indications]

Abstract

Prostate brachytherapy has been for a long time one of the standard treatments for low risk prostate cancer, with high rates of biochemical control and low levels of urinary and sexual late toxicity compared to other available techniques, namely external beam radiotherapy and radical prostatectomy. The aim of this article is to review the recent innovations of prostate brachytherapy, which suggest a bright future for the technique. We will discuss the extension of indications of permanent implant brachytherapy to favorable intermediate-risk patients, the use of novel isotopes such as Palladium 103 and Cesium 131, and the benefit of brachytherapy as a boost following external beam radiotherapy for intermediate and high-risk patients. We will also discuss the rise of high dose rate brachytherapy, as a boost or monotherapy, the increasing use of MRI for patient selection and treatment planning, as well as the development of brachytherapy as a means of focal therapy.

Keywords: Brachytherapy; Cancer de prostate; Curiethérapie; Focal therapy; Haut débit de dose; High dose rate; Imagerie par résonance magnétique; Implants permanents; Magnetic resonance imaging; Permanent implants; Prostate cancer; Traitement focal.